Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor

Journal of the European Academy of Dermatology and Venereology

Volumn 16, Issue 6, 2002, Pages 595-598

  Bianchi, L ^a   Ginebri, A ^b   Hagman, J H ^b   Francesconi, F ^b   Carboni, I ^b   Chimenti, S ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

Author keywords

Neuropathic diabetic ulcer; Recombinant granulocyte macrophage colony stimulating factor; Therapy; Venous ulcer

Indexed keywords

RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SODIUM CHLORIDE;

AGED; ARTICLE; BLOOD CELL COUNT; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; HUMAN; LEG ULCER; LEUKOCYTE COUNT; LOCAL THERAPY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; SIDE EFFECT; SKIN ULCER; TREATMENT OUTCOME; ULCER HEALING; VASCULAR LESION;

AGED; AGED, 80 AND OVER; FEMALE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; LEG ULCER; MALE; TIME FACTORS; WOUND HEALING;

EID: 0036853689     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2002.00526.x     Document Type: Article

References (25)

1. Agren MS, Eaglstein WH, Ferguson MW et al. Causes and effects of the chronic inflammation in venous leg ulcers. Acta Derm Venereol Suppl 2000; 210: 3-17.
2. Knighton DR, Ciresi K, Fiegel VD et al. Stimulation of repair in chronic, non-healing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 1990; 170: 56-60.
3. Brown GL, Nanney LB, Griffen J et al. Enhancement of wound healing by topical treatment with epidermal growth factor. N Engl Med 1989; 321: 76-79.
4. Robinson JC. Growth factors: therapeutic advances in wound healing. Ann Med 1993; 25: 535-538.
5. Sporn MB. A major advance in the use of growth factors to enhance wound healing. J Clin Invest 1993; 92: 2565-2566.
6. Kaplan G, Walsh G, Guido LS et al. Novel responses of human skin to intradermal recombinant granulocyte-macrophage colony stimulating factors: Langerhans cells recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med 1992; 175: 1717-1728.
7. da Costa MR, Ribeiro JFM, Aniceto C, Mendes M. Randomized, double-blind, placebo-controlled, dose-ranging study of granulocyte-macrophage colony-stimulating factor in patients with chronic leg ulcers. Wound Rep Regen 1999; 7: 17-25.
8. Jaschke E, Zabernigg A, Gattringer C. Recombinant human granulocyte-macrophage locally in low doses enhances healing and prevent recurrence of chronic venous ulcers. Int J Dermatol 1999; 38: 380-386.
9. Leitch IO, Kucukcelebi A, Robson MC. Inhibition of wound contraction by topical antimicrobials. Aust NZ J Surg 1993; 63(4): 289-293.
10. Robson M, Kucukcelebi A, Carp SS et al. Effects of granulocyte-macrophage colony-stimulating factor on wound contraction. Eur J Clin Microbiol Infect Dis 1994; 13 (Suppl. 2): 41-46.
11. Pojda Z, Struzyna J. Treatment of non-healing ulcers with rhGM-CSF and skin grafts. Lancet 1994; 343: 1154.
12. Ovilla R et al. GM-CSF mouthwashes as treatment for oral mucositis after intensive chemotherapy with or without bone marrow transplant. European Bone Marrow Transplant Conference, March. Abstract. 1994.
13. Bulvik S, Jacobs P. Pyoderma gangrenosum in myelodysplasia responding to granulocyte macrophage-colony stimulating factor (GM-CSF). Br J Dermatol 1997; 136: 637-638.
14. Alli N, Karakayali G, Kahraman I, Artuz F. Local intralesional therapy with rhGM-CSF for a large genital ulcer in Behçet's disease. Br J Dermatol 1997; 136: 639-640.
15. Boente P, Sampaio C, Brandao MA. Local perilesional therapy with rhGM-CSF for Kaposi sarcoma. Lancet 1993; 341: 1154.
16. Bécherel PA, Chosidow O, Berger E et al. Granulocyte-macrophage colony-stimulating factor in the management of severe ecthyma gangrenosum related to myelodysplastic syndrome. Arch Dermatol 1995; 131: 892-894.
17. Gaspari AA, Zalka AD, Payne D et al. Successful treatment of a generalized human papillomavirus infection with granulocyte-macrophage colony-stimulating factor and interferon gamma immunotherapy in a patient with a primary immunodeficiency and cyclic neutropenia. Arch Dermatol 1997; 133: 491-496.
18. Vaquerano JE, Codbury P, Treseler P et al. Regression of in-transit melanoma of the scalp with intralesional recombinant human granulocyte-macrophage colony-stimulating factor. Arch Dermatol 1999; 135: 1276-1277.
19. Wandl UB, Bayerische Ruck AG. GM-CSF in the treatment of skin ulceration in breast cancer: a case study describing the use of granulocyte-macrophage colony-stimulating factor to stimulate healing of an ulcerative cutaneous lesion in a patient with metastatic breast cancer. J Wound Care 1997; 6(4): 165-166.
20. Balslev E, Thomsen HK, Danielsen L, Warburg F. The occurrence of pericapillary fibrin in venous hypertension and ischaemic leg ulcers: an histopathological study. Br J Dermatol 1992; 126: 582-585.
21. Falanga V, Eaglstein WH. The 'trap' hypothesis of venous ulceration. Lancet 1993; 341: 1006-1008.
22. Braunstein S, Kaplan G, Gottlieb AB et al. GM-CSF activates regenerative epidermal growth and stimulates keratinocytes proliferation in human skin in vivo. J Invest Dermatol 1991; 103: 601-604.
23. Arnold F, O'Brien J, Cherry G. Granulocyte monocyte-colony stimulating factor as an agent for wound healing. A study evaluating the use of local injections of a genetically engineered growth factor in the management of wounds with a poor healing prognosis. J Wound Care 1995; 4(9): 400-402.
24. Hui EP, Chan ATC, Yeo W, Wickham NWR. Rapid healing of an indolent leg ulcer with topical rhGM-CSF. Aust NZJ Med 1996; 26: 420-421.
25. Duprè D, Schoenlaub P, Coloigner M, Plantin P. Réaction anaphylactique aprés injection locale de GM-CSF an cours d'un ulcére veineux de jambe. Ann Dermatol Venereol 1999; 126: 160-161.